Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer | Naviance

Computational Tool Developed to Predict Immunotherapy Outcomes for Patients with Metastatic Breast Cancer

Using computational tools, researchers from the Centro Oncológico Johns Hopkins Kimmel y el Johns Hopkins University School of Medicine have developed a method to assess which patients with metastatic triple-negative breast cancer could benefit from immunotherapy.

APRENDE MÁS

VER TODAS LAS NOTICIAS

Mensajes recientes

Lymph Node-Like Structures May Trigger the Demise of Cancer Tumors Drug Combination Prompts Immune Response in Some Resistant Pancreatic Cancers How Hypoxia Helps Cancer Spread Study Suggests a Healthy Diet May Help Keep Low Grade Prostate Cancer From Progressing to More Dangerous States During Active Surveillance Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models Johns Hopkins Joins Cancer AI Alliance AI ‘Liquid Biopsies’ Using Cell-Free DNA, Protein Biomarkers, Could Aid Early Detection of Ovarian Cancer A Common Culprit Drives Prostate Cancer Progression Immunotherapy Before and After Lung Cancer Surgery Reduces Death Risk, Disease Recurrence